TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address6701 FANNIN
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Miller A, Daum R, Wang T, Wu M, Tat C, Pfeiffer T, Navai S, Heczey A, Hegde M, Ahmed N, Whittle SB, Hill L, Martinez C, Krance R, Ramos CA, Rouce RH, Lulla P, Heslop HE, Omer B, Shekar M. Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 2024 May 08. PMID: 38819365.
      Citations:    Fields:    
    2. Shulman DS, Whittle SB, Surdez D, Bailey KM, de ?lava E, Yustein JT, Shlien A, Hayashi M, Bishop AJR, Crompton BD, DuBois SG, Shukla N, Leavey PJ, Lessnick SL, Kovar H, Delattre O, Gr?newald TGP, Antonescu CR, Roberts RD, Toretsky JA, Tirode F, Gorlick R, Janeway KA, Reed D, Lawlor ER, Grohar PJ. An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. NPJ Precis Oncol. 2022 Sep 17; 6(1):65. PMID: 36115869; PMCID: PMC9482616.
    3. Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HE. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24. PMID: 35325065; PMCID: PMC9346960.
      Citations:    Fields:    Translation:HumansCells
    4. Whittle SB, Fetzko S, Roy A, Venkatramani R. Soft Tissue and Visceral Organ Sarcomas With BCOR Alterations. J Pediatr Hematol Oncol. 2022 07 01; 44(5):195-200. PMID: 35537005; PMCID: PMC10026688.
      Citations:    Fields:    Translation:Humans
    5. Whittle S, Venkatramani R, Pack SD, Alaggio R, Vokuhl C, Rudzinski ER, Wulf AL, Gruver JR, Arnold MA, Hettmer S, Barr FG, Hawkins DS, Bisogno G, Sch?nstein A, Zin A, Merks JHM, Koscielniak E, Sparber-Sauer M. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis. Eur J Cancer. 2022 06; 168:56-64. PMID: 35452896; PMCID: PMC9123806.
      Citations:    Fields:    Translation:Humans
    6. Baday YI, Navai SA, Hicks MJ, Venkatramani R, Whittle SB. Pediatric liposarcoma: A case series and literature review. Pediatr Blood Cancer. 2021 12; 68(12):e29327. PMID: 34520106.
      Citations: 1     Fields:    Translation:Humans
    7. Whittle SB, Offer K, Roberts RD, LeBlanc A, London C, Majzner RG, Huang AY, Houghton P, Alejandro Sweet Cordero E, Grohar PJ, Isakoff M, Bishop MW, Stewart E, Slotkin EK, Greengard E, Borinstein SC, Navid F, Gorlick R, Janeway KA, Reed DR, Hingorani P. Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force. Pediatr Blood Cancer. 2021 09; 68(9):e29188. PMID: 34137164; PMCID: PMC8316376.
      Citations: 2     Fields:    Translation:Humans
    8. Hillier K, Cheng WS, Whittle SB, Krance R, Foster JH. Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant. J Pediatr Hematol Oncol. 2020 10; 42(7):e569-e574. PMID: 32032244.
      Citations: 1     Fields:    Translation:Humans
    9. Smith VR, Whittle SB, Coleman RD, Munoz FM, De Guzman MM, Foster JH, Navai SA. Severe COVID-19 infection in a child receiving immunotherapy for cancer. Pediatr Blood Cancer. 2021 03; 68(3):e28710. PMID: 32930438; PMCID: PMC7861044.
      Citations: 4     Fields:    Translation:HumansCells
    10. Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JH. Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417. PMID: 32729196; PMCID: PMC7722106.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    11. Silverstein A, Reddy K, Smith V, Foster JH, Russell HV, Whittle SB. Blood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14. PMID: 31829069; PMCID: PMC6942619.
      Citations:    Fields:    Translation:Humans
    12. Whittle SB, Hicks MJ, Roy A, Vasudevan SA, Reddy K, Venkatramani R. Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935. PMID: 31339226.
      Citations: 4     Fields:    Translation:Humans
    13. Whittle SB, Lopez MA, Russell HV. Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations. Pediatr Blood Cancer. 2019 07; 66(7):e27739. PMID: 30989762; PMCID: PMC7057732.
      Citations: 2     Fields:    Translation:Humans
    14. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors in Children and Adolescents: An Overview. Pediatr Rev. 2018 Sep; 39(9):444-453. PMID: 30171055.
      Citations: 5     Fields:    Translation:Humans
    15. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors of Infancy: An Overview. Pediatr Rev. 2018 Feb; 39(2):57-67. PMID: 29437125.
      Citations: 13     Fields:    Translation:Humans
    16. Lindsay H, Bhar S, Bonifant C, Sartain S, Whittle SB, Lee-Kim Y, Shah MD. Work efficiency improvement of >90% after implementation of an annual inpatient blood products administration consent form. BMJ Open Qual. 2018; 7(1):e000164. PMID: 29333497; PMCID: PMC5759742.
      Citations: 1     Fields:    
    17. Whittle SB, Williamson KC, Russell HV. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma. Pediatr Hematol Oncol. 2017 Aug; 34(5):331-342. PMID: 29200325; PMCID: PMC7185719.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    18. Punia JN, Gaikwad A, Hampton OA, Heczey A, Whittle SB, L?pez-Terrada D. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma. J Pediatr Hematol Oncol. 2017 11; 39(8):e486-e488. PMID: 28902076.
      Citations:    Fields:    Translation:HumansCells
    19. Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017 Apr; 17(4):369-386. PMID: 28142287.
      Citations: 102     Fields:    Translation:Humans
    20. Whittle SB, Patel K, Zhang L, Woodfield SE, Du M, Smith V, Zage PE. The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692. PMID: 27586230.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    21. Zage PE, Whittle SB, Shohet JM. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family. J Cell Biochem. 2017 02; 118(2):221-231. PMID: 27428599.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    22. Reyes S, Du M, Gireud M, Zhang L, Woodfield SE, Ittmann M, Scheurer ME, Bean AJ, Zage PE, Whittle SB. A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation. J Pediatr Hematol Oncol. 2016 Mar; 38(2):131-8. PMID: 26840079; PMCID: PMC4758892.
      Citations: 5     Fields:    Translation:Humans
    23. Woodfield SE, Guo RJ, Liu Y, Major AM, Hollingsworth EF, Indiviglio S, Whittle SB, Mo Q, Bean AJ, Ittmann M, Lopez-Terrada D, Zage PE. Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B. Genes Cancer. 2016 Jan; 7(1-2):13-26. PMID: 27014418; PMCID: PMC4773702.
      Citations: 5     
    24. Drolet BC, Whittle SB, Khokhar MT, Fischer SA, Pallant A. Approval and perceived impact of duty hour regulations: survey of pediatric program directors. Pediatrics. 2013 Nov; 132(5):819-24. PMID: 24101756.
      Citations: 11     Fields:    Translation:Humans
    25. Whittle S, Gosain A, Brown PY, Debelenko L, Raimondi S, Wilimas JA, Jenkins JJ, Davidoff AM. Regression of a congenital mesoblastic nephroma. Pediatr Blood Cancer. 2010 Aug; 55(2):364-8. PMID: 20582939; PMCID: PMC3049946.
      Citations: 3     Fields:    Translation:Humans
    26. McCarville MB, Whittle SB, Goodin GS, Li CS, Smeltzer MP, Hale GA, Kaufman RA. Clinical and CT features of benign pneumatosis intestinalis in pediatric hematopoietic stem cell transplant and oncology patients. Pediatr Radiol. 2008 Oct; 38(10):1074-83. PMID: 18665358; PMCID: PMC3612433.
      Citations: 9     Fields:    Translation:Humans
    WHITTLE's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (140)
    Co-Authors (47)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors